犬冠状动脉狭窄时血浆纤维连接蛋白的消耗

在实验犬上,观察了冠状动脉狭窄对冠状窦静脉血血浆纤维连接蛋白(Fn)含量的变化。结果表明:当冠脉狭窄程度大于75％时,冠状动脉狭窄可引起冠脉急性炎症反应和Fn的减少,此时伴有血小板聚集性和活性的增高。组织病理学检查证实有血管内皮细胞和毛细血管的损伤以及白细胞、血小板的沉积。 这一结果提示冠脉损伤后可引起冠脉循环中防御功能的减弱。     

冠状动脉狭窄对血流量的影响

在22条开胸犬上观察了冠脉狭窄对血流量(CBF)的影响。用一可调节的微米缩窄器定量调节左旋支缩窄程度,测量了主动脉平均压(Pa)、冠脉远端小动脉平均压(Pc)和狭窄端压力降(ΔP)。冠脉狭窄程度与血流量变化曲线显示:在冠脉狭窄程度小于85％时,CBF相对稳定;随着狭窄程度的进一步增加,CBF急剧下降;而在狭窄程度大于95％后,CBF又缓慢下降。冠状动脉狭窄程度与CBF下降的曲线可用下列方程式表达: CBF=1.48×10~(10)e~(-27.6A)(A=冠脉狭窄程度) 冠脉狭窄程度大于50％时,狭窄程度与Pc呈负相关:Pc=159.1—1.36A(r=-0.73,P<0.01)。Pc与CBF呈正相关;Pc=16.9 1.3CBF(r=0.74,P<0.01)     

ANTICOAGULANT DRUG TREATMENT OF CORONARY ARTERY DISEASE

Anticoagulant therapy of arteriosclerotic heart disease may prove to be most valuable when applied on a long-term basis for prevention of recurrent myocardial infarction. While its prophylactic value in impending infarction has not been established, at least the accepted treatment for the acute stage is already begun if an anticoagulant has been administered before an inevitable infarction occurs.The chief value of the anticoagulant, though, seems to lie in preventing cardiac mural thrombosis and extracardiac thromboembolism. It is by this effect, apparently, that mortality has been reduced by 50 per cent among survivors of myocardial infarction who receive continuous dicoumarin therapy.While the danger of hemorrhage is still present, it is being steadily reduced by increasing skill in the management of anticoagulant therapy, and for a long time the risk has been far outweighed by the reduction in coronary occlusion.Physicians have a duty to learn the use of anticoagulant therapy, obtain the facilities necessary for it, and apply it to patients who are able and willing to cooperate in prolonging their useful lives.     

NONCARDIAC SURGERY COMBINED WITH CORONARY ARTERY BYPASS

The coexistence of coronary artery disease with noncardiac disease often leads to a dilemma in planning therapeutic procedures. This problem is especially difficult in the presence of accelerated angina or left coronary artery stenosis. A series of 17 patients is presented in which coronary artery bypass grafts were combined with noncardiac operations without mortality or significant morbidity. An illustrative case report shows the interrelated nature of the coexisting disorders. The conclusion of this study is that, at times, various surgical procedures should be combined with coronary artery bypass grafting for a smoother, less complicated recovery. However, there are no hard and fast rules dictating combined procedures; each operation must be planned according to the existing conditions and needs of the individual patient.     

降钙素基因相关肽和心房肽对犬冠脉的舒张作用

本实验利用冠脉内给药和离体血管灌流等方法观察比较了降钙素基因相关肽（ＣＧＲＰ）和心房肽（ＡＮＰ）对犬冠脉循环的影响及其对犬大小冠状动脉的舒张作用。结果显示,ＣＧＲＰ和ＡＮＰ均能明显增加冠脉血流量、降低大小冠脉阻力,两者均呈剂量依赖性舒张大小脉冠脉血管。ＡＮＰ的作用显著小于ＣＧＲＰ,其中大冠脉对两者的反应性显著小于小冠脉,ＣＧＲＰ和ＡＮＰ对冠脉的舒张作用均无内皮依赖性。结果提示,ＣＧＲＰ和ＡＮＰ直接     

LEFT MAIN CORONARY ARTERY OCCLUSION: SURGICAL MANAGEMENT

Left main coronary occlusion is a rare lesion. A case that was successfully managed by coronary bypass surgery is presented. Occlusion of the left main coronary artery and management of left main coronary artery disease is discussed.